Diapath SPA

Diapath SPA Diapath is a specialized company, completely made in Italy, that manufactures Instruments an Subject
2. Principles
3. Access mode
4. Community Rules
5.

REGULATION FOR THE USE OF SOCIAL MEDIA
(External Social Media Policy)

SUMMARY

1. Supervision of the contents and responsibility of the users
6. Post content
7. Restraint
8. Legislation on Privacy
9. Validity and updates

1. Subject
The document called "Regulations for the use of social media" governs the management and operation of the institutional pages of the company Diapath Spa, Diapath f

or short, on social networks, defining the methods of publication and access to the information contained therein. This document also defines the guidelines ("netiquette") for the use of social media. The same integrates the external social media policy, i.e. the information addressed to users about the purposes, types of content and behaviors allowed on the institutional pages/profiles created.


2. Principles
Diapath recognizes social networks as fundamental tools for the externalization of freedom of thought and expression as sanctioned by article 21 of the Constitution of the Italian Republic and article 10 of the European Convention for the protection of human rights and freedoms fundamental. The presence on social networks represents a necessary implementation of the traditional tools with which Diapath transmits all news and initiatives concerning the products and services offered. These innovative tools will help to improve the effectiveness and timeliness of information by facilitating customer knowledge of the products, commercial policies, company features, all in order to ensure implementation and greater dissemination on the market. The page on social networks therefore represents an institutional virtual place for exchanging information. Diapath social channels are spaces designed and created to convey information on the services provided and products marketed and to promote dialogue with customers.



3. Access Mode
Each user can access each social channel after personal access and registration to the reference platforms. It is understood that upon registering on the Facebook, Linkedin, Instagram, Youtube, Tik Tok and Wechat platforms, the user accepts all the rules and conditions contained therein. The same also remain valid for Diapath. Each user is civilly and criminally liable for infringement of Copyright-protected access and user licenses. The publication of the contents is subject to a moderation procedure in case of non-compliance with the policies indicated in the following regulation. Diapath in the event that activities that could lead to a crime are identified, will make a report to the judicial authority. Diapath employees, with the eventual technical supervision of the system administrator (external), compatibly with the structural peculiarities of each social media, ensure to:
• Manage profile authorizations;
• Make the appropriate communications to the Diapath structures;
• Log in with "username" and "password";
• Update their access profiles and any other technical requirements.

4. Community Rules
Any contribution from users, including constructive criticism, is appreciated by Diapath. Consistent with the rules of the community, the page administrators promote a dialogue based on courtesy, respect and education towards and between users. Diapath may occasionally share and relaunch content and messages of public interest and usefulness made by third parties (other entities, municipal administrations, etc.), while verifying, as far as possible, their accuracy and reliability. Diapath assumes no responsibility for any incorrect or outdated information published by third parties. Please note that the pages and accounts on social networks are not official channels for collecting reports or complaints. For these purposes it is necessary to send an email to [email protected]. Comments, photos, videos and other graphic material inserted must comply with the requirements of general interest, positive criticism, respect for the privacy of people. Behaviors allowed for Facebook users:
Users who interact with the Diapath page on Facebook can:
• appreciate the contents (posts) published on the Diapath bulletin board by clicking "Like";
• comment on the contents (posts) published on the Diapath bulletin board (news, photos, videos, events and links);
• share the contents (posts) published on the Diapath bulletin board in your own wall;
• send private messages from your personal account to the Diapath page. Facebook users are not allowed to independently publish content on the bulletin board of the Diapath institutional page. Behaviors allowed for Instagram users:
Users who interact with Diapath institutional profile can:
• write, using your personal account, messages (tweets) intended for Diapath (it is not necessary to follow closely, that is, to be a Diapath "follower");
• write, using your personal account, private messages to the Diapath account (you must be a Diapath follower);
• forward ("retweet") to their followers the messages (tweets) published by Diapath with their own institutional account.

5. Supervision of the contents and responsibility of the users
Each individual user of the service must behave in a manner that respects ethics and the rules of good use of network services and is liable, civilly and criminally, in accordance with the laws in force, for the messages he sends, opinions he expresses and the contents he publishes within the social media pages. The page manager may modify, refuse to insert or remove any material that violates the rules of these Regulations. For this purpose, the most appropriate moderation rules will be used from time to time. The infringement of one of the community rules may lead to the recall via message of the user and, in the most serious cases, to the blocking and/or ban of the account from any type of future interaction with the page, with the notification sent to the managers of the platform and, if necessary, to the competent Authorities.

6. Post content
The contents published by Diapath on its official social accounts, unless otherwise indicated, are the property of Diapath and covered by copyright. They can be used by third parties only by citing the source of origin and without them being modified. They must comply with the company's code of ethics, available on the company website and with these Regulations. Furthermore, comments or contents with the following characteristics are not welcome and, in any case, subject to moderation:
• Interventions entered repeatedly;
• Comments not relevant to that particular topic;
• Offensive language or content;
• Comments or posts written to disturb the discussion or offend those who manage and moderate the social channels;
• Spam content.

7. Restraint
Moderation by Diapath within its own spaces takes place subsequently, or at a time following publication, and is aimed solely at containing, within the reasonable time and manner, of any behavior contrary to the rules of use. Diapath social spaces are reviewed, as a rule, from Monday to Friday. Diapath undertakes to read the messages and to provide, if requested, an answer. If the social channels are not the adequate tool to satisfy the request, the manager will inform about the correct procedures and the offices to contact. Diapath invites to have a polite, relevant and respectful conversation. On Diapath social channels everyone can intervene to express their free opinion, always following the good rules of education and respect for others. Any comments and posts that violate the conditions set out in this regulation will be moderated, even in advance, and promptly removed. Insults, foul language, threats or attitudes that damage the dignity of persons and the dignity of the institutions, the rights of minorities and minors and the principles of freedom will not be tolerated. All messages will be removed that:
• have content that promotes, fosters discrimination on the basis of sex, race, language, religion, sexual orientation, political opinions, age, nationality, mental or physical disability;
• encourage the conduct of illegal activities;
• contain information that may compromise the security of Diapath services and/or systems;
• have content that violates the interest of legal property or third parties;
• contain data that are in violation of the European Regulation and national legislation concerning the protection of personal data;
• contain messages or references to links to sexual content;
• have content that is offensive and disparaging to people;
• have contents contrary to the principles of the company code of ethics.

8. Legislation on Privacy
The processing of users' personal data responds to the policies in use on the platforms used (Facebook, etc.). The data that are shared by users through private messages sent directly to Diapath channels will be processed in compliance with the provisions of Regulation (EU) 679/2016, Legislative Decree 196/2003, Legislative Decree 101/2018 and the provisions of the Guarantor as compatible. Data collection is carried out in compliance with the principles of adequacy, relevance and limitation with reference to the purposes of the treatments to be carried out. Users can report copyright infringements or abuses to Diapath. The complete information on the corporate privacy policy can be downloaded from the website at www.Diapath.com



9. Validity and updates
These regulations were approved by the Board of Directors of the Company in the session of 15th Jul 2021 and will be promptly revised and updated if necessary. The same comes into force on the day 15th Jul 2021, and can be downloaded in the latest updated version from the company website.

Heading for the finish line, together. 🏃‍♀️Last weekend, Team Diapath joined .it  2026 in Bergamo, stepping away from th...
17/06/2026

Heading for the finish line, together. 🏃‍♀️

Last weekend, Team Diapath joined .it 2026 in Bergamo, stepping away from the lab and office to celebrate what truly matters: well-being, movement, community and solidarity.

More than a run, StraWoman is a charity challenge supporting meaningful causes through WeWorld and Humanitas Medical Care , promoting women’s empowerment, prevention and health.

At Diapath, caring for people is part of who we are, inside and outside the workplace.

A heartfelt thank you to all our colleagues (both men and women!) who took part and made this day even more special.

Driving the future of healthcare through sustainability and innovation. Diapath present at the National Association Of C...
16/06/2026

Driving the future of healthcare through sustainability and innovation.

Diapath present at the National Association Of Clinical Engineering Conference AIIC 2026, June 11-13, Turin.

Our Head of Innovation, Carmelo Lupo, took the Innovation Theatre stage to present: "Sustainability and standardization in pathology laboratories: the role of StainTabs Technology".

Competing in the Green Health and Technological Innovation category, we showcased how StainTabs Line cutting-edge technology can concretely reduce environmental impact while enhancing laboratory precision.

Thank you to Associazione Italiana Ingegneria Clinica for an inspiring event. The future of healthcare is green, standardized, and innovative!

AFH Nîmes 2026Thank you to everyone who stepped inside the future of   innovation with us. It was a pleasure sharing the...
15/06/2026

AFH Nîmes 2026

Thank you to everyone who stepped inside the future of innovation with us.

It was a pleasure sharing the Line in person, presenting The New Shape of H&E Staining, and starting conversations that will redefine efficiency.

👉 Swipe through the photos to see some of the best moments from our exclusive workshop and booth!

11/06/2026

Our team is ready to welcome you in Nîmes!

Step inside the future of staining innovation. Beyond the event itself, come experience the StainTabs Line in person and discover The New Shape of H&E Staining.

👉 Join us for an exclusive workshop
📍 Centre des Congrès de Nîmes (39e Congrès AFH)

10/06/2026

What happens when one of the UK’s leading voices in cellular pathology evaluates the new StainTabs Line?

Dr. Guy Orchard, Laboratory Manager at Synnovis Analytics (Guy’s and St. Thomas’ Hospitals) and Chief Examiner for the IBMS, shares his independent perspective after months of active testing on both diagnostic paraffin processed material and frozen sections.

In this exclusive video, Dr. Orchard highlights how StainTabs addresses the critical operational challenges of modern, high-throughput laboratories.

Watch the full video to discover why Dr. Orchard defines StainTabs as "one of the most advanced, innovative concepts" in his entire career.

Explore the future of H&E workflow: 👉 diapath-staintabsline.com

Only 9 days left! | Digital Pathology: What, How, WhyThe digital transformation of pathology is no longer the future, it...
09/06/2026

Only 9 days left! | Digital Pathology: What, How, Why

The digital transformation of pathology is no longer the future, it is happening now. Are you ready to optimize your lab's workflow?

Join us next Thursday, June 18, for a new episode of Diapath Lab Talks.
Our guest speaker Dr. Arrigo Capitanio (Linköping University Hospital, Sweden) will share exclusive insights on transitioning to a digital workflow, from practical implementation to real clinical benefits.

Moderated by: Prof. Claudio Doglioni
Seats are filling up fast. Choose the session that best fits your schedule and secure your spot today:
• Morning Session: 10:00 AM CET
• Afternoon Session: 04:00 PM CET

👉 Don't miss out, register here: https://diapathlabtalks.com/webinar/digital-pathology-what-how-why/

Counting down to the 49es Assises de Pathologie! If you are attending, make sure to stop by the Diapath booth to explore...
03/06/2026

Counting down to the 49es Assises de Pathologie!

If you are attending, make sure to stop by the Diapath booth to explore our latest advancements in anatomic pathology and connect with our team.

Don’t miss our exclusive Symposium: Join Dr. Lorenzo Nibid as he presents crucial insights on standardizing H&E staining to elevate histopathological consistency, drawing from the VEED project.

📅 Save the Date:
• Where: Booth #08 | Palais des Congrès, Le Touquet-Paris-Plage
• When: 11 - 12 June 2026
• Symposium Session: 12 June | 12:15 - 12:30

We look forward to meeting you in Le Touquet and shaping the future of pathology together. See you there!

27/05/2026

Heading for the starting line! 🏃‍♀️

The Diapath Team is ready to lace up and join the StraWoman run in Bergamo on June 13th.

We are stepping out of the office and onto the track to celebrate health, empowerment, and the power of running together. It's all about high energy, true team spirit, and coming together to support a wonderful cause.

We can't wait to share the energy of this day with our amazing team. See you Bergamo!

👉 All the event details here: https://www.strawoman.com/bergamo-13-giugno-2026/

26/05/2026

The New Shape of H&E Staining is here.
StainTabs Line by Diapath.

Imagine transforming your staining routine into a streamlined, controlled and eco-friendly process, with diagnostic excellence.

Developed as solid-tablet formulations of Hematoxylin and Eosin, they combine active staining agents with stabilizing components in a controlled, reproducible format. This pharmaceutical-inspired approach minimizes intrinsic variability, ensuring stability, consistency and high-performance staining.

Why choose StainTabs Line?
• Simple: Precision staining has never been this effortless. Just drop it in deionized water. Done.
• Sustainable: Less packaging, easier disposal. A sustainable alternative that reduces plastic waste.
• Standardized: Freshly reconstituted stain prepared directly in the laboratory, preventing reagent aging.

Discover more on the World of StainTabs Line: 👉 diapath-staintabsline.com

Driving excellence through global synergy.We were honored to welcome two leading voices in international diagnostics and...
22/05/2026

Driving excellence through global synergy.

We were honored to welcome two leading voices in international diagnostics and pathology to Diapath headquarters: Dr. Guy Orchard, Operational Manager at Synnovis Analytics from Guy’s and St. Thomas’ Hospitals, and Mohammad Shams, Sr. Biomedical Scientist & Lecturer.

Engaging directly with leaders at the forefront of clinical practice and biomedical education empowers us to continuously refine our solutions. Together, we ensure total reliability and the highest standards for laboratories worldwide.

Thank you for an inspiring visit and a shared vision for the future of healthcare.

Indirizzo

Via Savoldini, 71
Martinengo
24057

Orario di apertura

Lunedì 08:30 - 17:30
Martedì 08:30 - 17:30
Mercoledì 08:30 - 17:30
Giovedì 08:30 - 17:30
Venerdì 08:30 - 17:30

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Diapath SPA pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Condividi